Login
Navigate Fool.com
Will MLAB beat
the market?
Community Rating: 5 Stars: The Best

53.10 -0.14 (-0.26%)

REAL-TIME: Last trade at

Extended Hours: $53.10 $0.00 (0.00%)
Quote as of (NASDAQ)


company name or ticker

Recent Quotes

1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $52.85
Previous Close $53.24
Daily Range $52.85 - $53.40
52-Week Range $40.00 - $57.00
Market Cap $180.3M
P/E Ratio 22.66
Dividend (Yield) $0.56 (1.1%)
Ex-Dividend Date
Dividend Pay Date
05/22/13
06/14/13
Volume 4,155
Average Daily Volume 26,018
Current FY EPS $0.00

How do you think MLAB
will perform against the market?

Top MLAB Bull/Bear Pitches

 

rexlove (< 20)
Submitted August 10, 2011

low peg

0 Replies Reply Report this Post
 

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches here!

News & Commentary

What Mesa Laboratories's Earnings Headlines Didn't Tell You

Don't just count the cash, time it.

Mesa Laboratories, Inc. (MLAB) Ex-Dividend Date Scheduled for May 22, 2013

Why the Street Should Love Mesa Laboratories's Earnings

All cash flow is not created equal.

Mesa Laboratories, Inc. (MLAB) Ex-Dividend Date Scheduled for February 25, 2013

Will National Beverage Shareholders Get a Significant Special Dividend Before December 31?

It's likely. And if not, long term investors should still do well -- just as they have over the past 20 years.

FDA Clears Teleflex's Latest PICC - Analyst Blog

Teleflex Acquires Semprus BioSciences - Analyst Blog

FDA Clears Teleflex's Catheter - Analyst Blog

FDA Clears Teleflex's Catheter - Analyst Blog

Delcath Prices Stock and Warrants - Analyst Blog

100 Best Small Companies in America

See More MLAB News...

Sector

Healthcare

Industry

Healthcare Information Services

MESA LABORATORIES, INC. (MLAB) Description

The Company designs, develops, acquires, manufactures and markets instruments and disposable products utilized in connection with industrial applications and healthcare. Website: http://www.mesalabs.com/

Featured Broker Partners

Learn more about our new Fool ticker page!

Take a Tour
no thanks